
Autoantibodies implicated as drivers of long COVID in new study
A growing body of evidence suggests that long COVID (or post-COVID syndrome), a condition affecting more than 10% of people after a SARS-CoV-2 infection, may be driven by the immune system turning against the body. Now, new research coordinated by UMC Utrecht and Amsterdam UMC provides some of the strongest functional evidence yet that autoantibodies (antibodies that mistakenly target the body's own tissues) could play a causal role. The work appears in Cell Reports Medicine.